walkitout (walkitout) wrote,
walkitout
walkitout

"Your Margin is My Opportunity", Shkreli edition

http://arstechnica.com/science/2015/10/drug-with-rage-inducing-5000-price-hike-now-has-1pill-competitor/

You may recall that Turing Pharmaceuticals/Martin Shkreli (you know, the guy whose name you can't remember partly because he has terrible social skills, partly because of the red haze of rage associated with reading any article about what he did, partly because you've never heard that name before) raised the price on a generic that they were the sole manufacturer of.

Well, there are a lot of ways to describe what happened to him next, but it wasn't effective regulation. Because I used to work for the guy most associated with this phrase, I like "Your Margin is My Opportunity". But I'll take Commodity Hell, Low Barriers to Entry, Invisible Hand or Supply and Demand as well. Same old, same old.

Even better, "Imprimis Pharmaceuticals, Inc., a specialty pharmaceutical company based in San Diego, announced today that it has made an alternative to Daraprim that costs about a buck a pill—or $99 for a 100-pill supply." has produced an improved alternative -- combining the drug in question with another one to reduce its primary negative side effect.
Tags: economics
Subscribe

  • French Canadians

    A post by my cousin on FB prompted me to take another shot at figuring out the ancestry of her mother (her father and my mother are siblings; for a…

  • Finding a marriage record

    One of my husband's relatives is slowly working through an application process that involves some minor genealogical research. The task that she was…

  • Nell Painter asks a really great question

    At the NYT, Nell Irvin Painter asks a great question, and provides her answer to it, along with some historical background and a proposal for a good…

  • Post a new comment

    Error

    default userpic

    Your reply will be screened

    Your IP address will be recorded 

    When you submit the form an invisible reCAPTCHA check will be performed.
    You must follow the Privacy Policy and Google Terms of use.
  • 0 comments